These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 18621671)

  • 21. Analysis of drug-induced effect patterns to link structure and side effects of medicines.
    Fliri AF; Loging WT; Thadeio PF; Volkmann RA
    Nat Chem Biol; 2005 Dec; 1(7):389-97. PubMed ID: 16370374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fast Identification of Adverse Drug Reactions (ADRs) of Digestive and Nervous Systems of Organic Drugs by In Silico Models.
    Chen M; Yang Z; Gao Y; Li C
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33578679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive prediction of drug-protein interactions and side effects for the human proteome.
    Zhou H; Gao M; Skolnick J
    Sci Rep; 2015 Jun; 5():11090. PubMed ID: 26057345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overheating of drugs during shipping and storage.
    Newton DW
    South Med J; 1995 Jun; 88(6):694-5. PubMed ID: 7777896
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction of adverse drug reactions using decision tree modeling.
    Hammann F; Gutmann H; Vogt N; Helma C; Drewe J
    Clin Pharmacol Ther; 2010 Jul; 88(1):52-9. PubMed ID: 20220749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying Drug-Target Interactions with Decision Templates.
    Yan XY; Zhang SW
    Curr Protein Pept Sci; 2018; 19(5):498-506. PubMed ID: 27829344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports.
    Liu R; Zhang P
    BMC Med Inform Decis Mak; 2019 Dec; 19(1):279. PubMed ID: 31849321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similarity-based prediction for Anatomical Therapeutic Chemical classification of drugs by integrating multiple data sources.
    Liu Z; Guo F; Gu J; Wang Y; Li Y; Wang D; Lu L; Li D; He F
    Bioinformatics; 2015 Jun; 31(11):1788-95. PubMed ID: 25638810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relating drug-protein interaction network with drug side effects.
    Mizutani S; Pauwels E; Stoven V; Goto S; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i522-i528. PubMed ID: 22962476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico screening of drug databases for TSE inhibitors.
    Lorenzen S; Dunkel M; Preissner R
    Biosystems; 2005 May; 80(2):117-22. PubMed ID: 15823410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-scale prediction of drug-target relationships.
    Kuhn M; Campillos M; González P; Jensen LJ; Bork P
    FEBS Lett; 2008 Apr; 582(8):1283-90. PubMed ID: 18291108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicines containing pharmaceutical excipients with known effects: a French review.
    Fusier I; Tollier C; Husson MC
    Pharm World Sci; 2003 Aug; 25(4):152-5. PubMed ID: 12964493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network neighbors of drug targets contribute to drug side-effect similarity.
    Brouwers L; Iskar M; Zeller G; van Noort V; Bork P
    PLoS One; 2011; 6(7):e22187. PubMed ID: 21765950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrostatic-field and surface-shape similarity for virtual screening and pose prediction.
    Cleves AE; Johnson SR; Jain AN
    J Comput Aided Mol Des; 2019 Oct; 33(10):865-886. PubMed ID: 31650386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug bioactivation, covalent binding to target proteins and toxicity relevance.
    Zhou S; Chan E; Duan W; Huang M; Chen YZ
    Drug Metab Rev; 2005; 37(1):41-213. PubMed ID: 15747500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Cell Phenotypic Screening Illuminates ADRs and AOPs.
    Bone AJ; Houck KA
    Cell Chem Biol; 2017 Jul; 24(7):781-782. PubMed ID: 28732198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting potential adverse events using safety data from marketed drugs.
    Daluwatte C; Schotland P; Strauss DG; Burkhart KK; Racz R
    BMC Bioinformatics; 2020 Apr; 21(1):163. PubMed ID: 32349656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large-scale prediction and testing of drug activity on side-effect targets.
    Lounkine E; Keiser MJ; Whitebread S; Mikhailov D; Hamon J; Jenkins JL; Lavan P; Weber E; Doak AK; Côté S; Shoichet BK; Urban L
    Nature; 2012 Jun; 486(7403):361-7. PubMed ID: 22722194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global optimization-based inference of chemogenomic features from drug-target interactions.
    Zu S; Chen T; Li S
    Bioinformatics; 2015 Aug; 31(15):2523-9. PubMed ID: 25819672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic side effects prediction by optimizing correlation with chemical and target profiles of drugs.
    Kanji R; Sharma A; Bagler G
    Mol Biosyst; 2015 Nov; 11(11):2900-6. PubMed ID: 26252576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.